SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-254339
Filing Date
2010-11-09
Accepted
2010-11-09 17:01:09
Documents
4
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 396698
2 RULE 13A-14 (A) / 15D - 14 (A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6267
3 RULE 13A-14 (A) / 15D - 14 (A) CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6246
4 SECTION 1350 CERTIFICATION dex32.htm EX-32 3739
  Complete submission text file 0001193125-10-254339.txt   414708
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 101177003
SIC: 2836 Biological Products, (No Diagnostic Substances)